Detalles de la búsqueda
1.
Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.
Nat Genet
; 39(8): 957-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17632512
2.
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.
Proc Natl Acad Sci U S A
; 109(7): 2358-63, 2012 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22308459
3.
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
Proc Natl Acad Sci U S A
; 107(44): 18874-9, 2010 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20952655
4.
Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Lab Invest
; 91(11): 1605-14, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21808236
5.
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.
Gynecol Oncol
; 120(1): 128-34, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21056908
6.
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct.
Dev Biol
; 325(2): 351-62, 2009 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19013450
7.
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.
Protein Expr Purif
; 70(1): 32-8, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19755162
8.
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.
Future Oncol
; 6(3): 391-405, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20222796
9.
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Int J Oncol
; 34(6): 1583-91, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19424576
10.
Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.
Gynecol Oncol
; 114(1): 57-60, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19359032
11.
Identification of large-scale characteristic genes of Müllerian inhibiting substance in human ovarian cancer cells.
Int J Mol Med
; 23(5): 589-96, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19360316
12.
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Cancer Res
; 67(6): 2747-56, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363596
13.
Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
Clin Cancer Res
; 12(5): 1593-8, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16533786
14.
Müllerian inhibiting substance inhibits an ovarian cancer cell line via ß-catenin interacting protein deregulation of the Wnt signal pathway.
Int J Oncol
; 50(3): 1022-1028, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28197641
15.
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
Fertil Steril
; 83(1): 130-6, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15652898
16.
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
Clin Cancer Res
; 8(8): 2640-6, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12171896
17.
Transcriptome analysis reveals that Müllerian inhibiting substance regulates signaling pathways that contribute to endometrial carcinogenesis.
Int J Oncol
; 46(5): 2039-46, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25760378
18.
The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.
J Clin Endocrinol Metab
; 88(2): 787-92, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12574214
19.
Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.
J Clin Endocrinol Metab
; 87(8): 3598-602, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12161481
20.
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism.
J Clin Endocrinol Metab
; 87(1): 152-60, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11788640